Skip to content
Erudio Health
menu
Clinical trial · no report yet · Phase 3

TRITONS

Total RadIoTherapy of Oligometastatic caNcerS

We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.

Preliminary discovery

Commentary in our index that names this trial so far

Podcasts, YouTube videos and X posts we have indexed. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build.

ChannelFound
X threads6
Bluesky threads1

The trial

ClinicalTrials.gov
Official title
Total RadIoTherapy of Oligometastatic caNcerS (TRITONS)
Phase
Phase 3
Status
Recruiting
Conditions
Oligometastatic Malignant Solid Neoplasm
Interventions
stereotactic ablative radiotherapy
Arms
  • SABR+SOC · Experimental
  • SOC · No intervention
Enrollment
300 (estimated)
Primary outcomes
  • Progression-Free Survival (PFS)
Sponsor
University of California, San Diego
Start
Nov 12, 2024
Primary completion
Nov 2033 (estimated)
Results posted
No
Registry record
NCT06587490 · updated Oct 16, 2026